Company to Deploy Gene Editing for Alpha-1 Disease
Prime Medical will use its gene editing platform to correct the gene mutations that lead to alpha-1 antitrypsin deficiency (AATD) lung disease and liver disease.
Category: COPD
COPD
Latest
Company to Deploy Gene Editing for Alpha-1 Disease
Prime Medical will use its gene editing platform to correct the gene mutations that lead to alpha-1 antitrypsin deficiency (AATD) lung disease and liver disease.
Read More
Statins, Aspirin and Chest Muscle Loss in Smokers
A study of current and former smokers reveals positive and negative effects of common medications like statins and aspirin on chest muscle loss.
Read More
Greater Mortality Risk for Concurrent COPD and Arthritis
An analysis of 11,000 COPD patients found a significant association between COPD and increased mortality rates for people with arthritis.
Read More
Mental Health Being Ignored in COPD Patients
Mental health disorders in people with COPD are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life.
Read More
Film Documenting Leonard Nimoy’s Battle with COPD Gets Second Release
Ten years after Leonard Nimoy’s death from COPD a documentary covering the actor’s struggle with the disease is being re-released via a partnership by The COPD Foundation, The Nimoy Knight Foundation, and Health Point Productions.
Read More
COPD Patients Face Higher Fall Risk When Taking Common Medications
Nearly one-third of COPD patients prescribed fall-risk medications experienced injuries in the two years before death.
Read More
8 Considerations for Delivering Oxygen Therapy to COPD Patients
As COPD progresses, a combination of pathological changes occur in the lungs which necessitate oxygen therapy, which may be delivered in both the acute care and home care settings.
Read More
A Call to Integrate Patient Perspectives in COPD Drug Development
New commentary highlights the need for patient-inspired frameworks to guide COPD therapy development.
Read More
Urine Test Predicts COPD Flare-Ups a Week in Advance
Researchers used artificial intelligence to analyze urine samples, accurately forecasting COPD symptom flare-ups seven days before they occurred.
Read More
Vitamin B3 Reduces Lung Inflammation in COPD Patients
A new study suggests that a form of vitamin B3 may be the key to improving quality of life for patients with COPD.
Read More
World COPD Day Highlights Spirometry
On November 20, the healthcare industry recognizes World COPD Day 2024 with an emphasis on importance of measuring lung function, also known as spirometry.
Read More
Olympus America Celebrates COPD Awareness Month
During COPD Awareness Month, Olympus Corp of the Americas is celebrating strides in emphysema treatment.
Read More
2025 GOLD Report on COPD
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has posted a draft of its annual 2025 GOLD Report on COPD diagnosis, management, and prevention.
Read More
Researchers Study Early Warning Signs of COPD in Younger Smokers
Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD.
Read More
COPD Foundation Debunks 7 Common COPD Myths
November is COPD Awareness Month and the COPD Foundation is working to better inform the community about the disease by debunking common myths.
Read More
COPD Acoustic Patch Developer Secures $350K MedTech Innovation Prize
The startup, selected as the top prize winner by med-tech industry leaders, will use the funding to advance its acoustic resonance patch for COPD.
Read MoreOn-demand Webinar: Respiratory COPD Solutions from Hospital Care Home Care
RT’s webinar on COPD hospital and home care solutions is now available for on-demand viewing.
Read More
How to Help Patients Adhere to Airway Clearance Therapy at Home
Adherence to airway clearance therapy in the home is crucial for managing chronic lung conditions, but challenges like time constraints and lack of perceived benefit can hinder patient compliance. Experts offer strategies and new technologies to help improve patients’ adherence.
Read More
FDA Approves Dupixent for COPD
The FDA has approved Dupixent for adults with inadequately controlled COPD and an eosinophilic phenotype.
Read More
Vaping Predicted to Have Notable Impact on Europe’s COPD Burden
Research predicts that vaping—in addition to smoking and air pollution—will increase the burden of COPD in Western Europe by 2050, while home NIV is expected to reduce mortality from COPD exacerbations.
Read More
Smartphone Voice Analysis Detects Early COPD Exacerbations
A pilot study suggests that changes in voice patterns recorded via smartphone may help detect early flare-ups in chronic obstructive pulmonary disease.
Read More
Genetic Risk for COPD Linked to Lower Lung Function from Childhood
A new study finds individuals with higher genetic risk for COPD show lower lung function starting in childhood.
Read More
Inhaling Lactobacilli Bacteria Shows Promise in Treating BPD and COPD
This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.
Read More
Two-thirds of Patients Hospitalized for COPD Misuse Inhalers, Study Finds
Incorrectly using inhalers results in poor drug delivery, prompting researchers to call for enhanced education to ensure effective treatment and improve health outcomes.
Read More